Moderna Will Submit For Emergency Use Authorization with FDA

Moderna announced that it will submit for an Emergency Use Authorization with the U.S. FDA and an application for Conditional Marketing Authorization with the European Medicines Agency for its Covid-19 vaccine mRNA-1273.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.